Key cautions
- High-dose EPA/DHA can increase atrial-fibrillation risk; review rhythm history and medicines
- Check anticoagulants/antiplatelets, allergies and actual EPA/DHA amounts; OTC blends do not replace prescriptions
What’s inside
Alpha-linolenic acid (ALA, 18:3 n-3), eicosapentaenoic acid (EPA, 20:5 n-3), docosahexaenoic acid (DHA, 22:6 n-3), linoleic acid (18:2 n-6) and oleic acid (18:1 n-9), in product-dependent amounts and forms. The numerical notation identifies carbon-chain length, double bonds and omega family. Cod-liver oil additionally contains vitamins A and D; other vitamins are not guaranteed by an omega label.
NIH Office of Dietary Supplements: Omega-3 fatty acids, health professional fact sheet
Uses in brief
- Food-based essential-fat nutrition; ALA differs from EPA/DHA
- Specific prescription omega-3 uses require the studied product and medical indication
History, folklore and reported uses
Marine oils and heart-health culture
Danish researchers’ comparisons of Greenlandic Inuit diets and blood fats in the 1970s helped popularize marine oils for cardiovascular protection. Later supplements and prescription products focused on eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), including use to lower triglycerides, a type of blood fat. Those population observations were not experiments proving that capsules or every omega blend prevent heart disease.
NIH Office of Dietary Supplements: Omega-3 fatty acids, health professional fact sheet · Bang and Dyerberg, 1972: Plasma lipids and lipoproteins in Greenlandic west-coast Inuit, original study under its historical title
Inflammatory joint discomfort
Modern complementary care uses marine omega-3 oils, and sometimes gamma-linolenic-acid-rich (GLA-rich) omega-6 oils from evening primrose, borage or blackcurrant, for rheumatoid-arthritis symptoms. The U.S. National Center for Complementary and Integrative Health documents these different oil traditions as additions to care rather than replacements for disease-modifying treatment.
Mood-related supplementation
Modern psychiatric nutrition has explored EPA- and DHA-containing fish oils for depression, often alongside standard treatment. This is a contemporary supplement use with uncertain benefit, not a historical indication attached to all fish-eating cultures.
Evening primrose oil for eczema
Late-twentieth-century natural-health practice promoted evening primrose seed oil, a GLA-containing omega-6 preparation, for atopic eczema, a chronic itchy inflammatory skin condition. The U.S. National Center for Complementary and Integrative Health records this oil-supplement claim separately from Indigenous uses of the plant’s leaves or stem juice.
Olive oil for cleansing and body care
Ancient Greek athletes used olive oil to cleanse their skin after exercise, as documented by surviving oil flasks in the Metropolitan Museum of Art in New York. Olive oil is rich in the omega-9 fat oleic acid, but this was a whole-oil practice, not a prescription for isolated omega-9 capsules.
Metropolitan Museum of Art: Archaic Greek oil flask used by athletes · NIH Office of Dietary Supplements: Omega-3 fatty acids, health professional fact sheet
Discovering that some fats are essential
In 1929 and 1930, George and Mildred Burr showed that removing fat rigorously from rats’ diets caused a distinctive deficiency. Fat was doing more than supplying interchangeable calories; their work helped establish essential fatty acids, especially linoleic acid. The omega numbers are modern chemical labels for fats carried by much older foods, including seeds, olive oil and marine foods. Certain omega-3 and omega-6 fats must come from food, whereas oleic acid, a common omega-9, is not an essential fatty acid.
American Society for Biochemistry and Molecular Biology: Essential Fatty Acids, the work of George and Mildred Burr · NIH Office of Dietary Supplements: Omega-3 fatty acids, health professional fact sheet
Health topics: evidence and cautions
These notes describe a specific research context and preparation. A topic link is not a treatment recommendation.
Male fertility & sperm health · Support during care
Form and route: Specified EPA/DHA oils, including EPAX 5500TG and DHA-enriched fish triglyceride oil · oral
Condition and setting: Semen quality and sperm DNA measures in fertility-clinic populations
Trials give mixed sperm-marker results. An EPA/DHA trial reported improved count and concentration; another improved DNA-fragmentation measures without conventional semen benefits. Pregnancy and live-birth benefit is unproven.
Evidence: Mixed surrogate-outcome evidence
2011: 238 randomized, 211 completed; EPA+DHA 1.84 g/day for 32 weeks. 2016: 74 randomized, 57 analyzed; DHA 990 mg plus EPA 135 mg/day for ten weeks.
Limits
Different formulations, attrition and surrogate outcomes limit confidence. The 2011 abstract reports baseline-to-end changes rather than a complete placebo-adjusted estimate. These trials do not test an omega-3/6/9 blend.
Cautions
- Fish-oil preparations may cause unpleasant taste, bad breath, heartburn or digestive upset. Discuss anticoagulants and other medicines with a clinician before supplementation.
Identity & detailed reference
Identity
A nutritional fatty-acid category, sometimes sold as a 3–6–9 blend, rather than one herb or oil. Omega-3 includes ALA, EPA and DHA; omega-6 includes linoleic acid; omega-9 commonly means oleic acid.
Ingredient details, preparation and research
Source plant or material
Mixed material sources: fish-body or fish-liver oil, krill, cultivated microalgae, flaxseed and other plant seeds/fruits. Marine EPA/DHA originates in microalgae and accumulates through the food chain. The ingredient list determines the actual source.
Plant family / material: No single plant family: this category includes animal, algal and multiple botanical sources.
Forms and route
Foods and food-grade oils; fish, krill or algal dietary supplements; plant-oil blends; and separate prescription EPA-only or EPA/DHA medicines. Products may contain triglycerides, re-esterified triglycerides, phospholipids, free fatty acids or ethyl esters. These are not dose-for-dose substitutes.
Food sources
Examples from NIH’s USDA-based table: 1 tablespoon flaxseed oil supplies 7.26 g ALA; 1 ounce (28 g) English walnuts supplies 2.57 g ALA; 1 tablespoon canola oil supplies 1.28 g ALA. A 3-ounce (85 g) cooked farmed Atlantic salmon portion supplies about 0.59 g EPA plus 1.24 g DHA. Values vary with source and processing. Nuts/seed oils also supply omega-6; olive oil and avocado supply omega-9.
Vitamins and minerals
U.S. adult ALA Adequate Intakes are 1.6 g/day for men and 1.1 g/day for women; linoleic acid AIs at ages 19–50 are 17 g/day and 12 g/day, respectively (ages 51+: 14 and 11 g/day). These are total dietary reference intakes, not supplement doses. No U.S. RDA is set for EPA/DHA or oleic acid. EFSA separately uses 250 mg/day EPA+DHA for adults. Food portions and product labels matter more than a “3–6–9” total.
Absorption and preparation
Intestinal uptake and ALA-to-EPA/DHA conversion are different processes. Co-ingestion with a meal can improve uptake, especially of ethyl esters; follow the product label rather than adding a high-fat meal solely for a capsule. No formulation is universally best, and better blood uptake does not establish superior clinical outcomes.
Practical preparation
Use edible oils in ordinary food portions and match the oil to the cooking method and label. Keep oils closed, away from heat/light, and follow refrigeration/expiry instructions; discard rancid oil. Oral supplements should follow their own directions, often with a meal. A prescription 4 g/day trial is not a kitchen or over-the-counter dosing instruction.
Combination notes
A 3–6–9 blend is not inherently better than food or a single clearly specified oil. Count ALA, EPA and DHA separately, alongside any added vitamins, and avoid duplicate high-dose products. No universal ratio, absorption booster or supplement stack is recommended.
Nutritional role and uses
- Nutrition: essential fatty acids, energy and cell-membrane components; unsaturated food fats can replace saturated fats in a balanced dietary pattern.
- Medical use: specific prescription products lower severe triglyceride elevations; icosapent ethyl also reduces cardiovascular events in defined statin-treated risk groups.
- General heart, cognitive and joint-support marketing is broader than the evidence for an unspecified supplement or 3–6–9 blend. Food benefits and drug-trial results cannot simply be assigned to every capsule.
- ALA from plants is useful nutrition, but limited conversion means it is not an equivalent gram-for-gram source of EPA or DHA.
Contraindications and cautions
- Higher-dose marine omega-3 formulations have increased atrial-fibrillation risk in cardiovascular trials. A prior rhythm disorder and high-dose use deserve clinician review; trial doses are not a personal regimen.
- Review anticoagulants/antiplatelets, bleeding disorders and planned procedures with the treating team. Bleeding risk is dose/product dependent; do not independently stop prescribed medicines or assume every dietary serving causes bleeding.
- Unpleasant taste, reflux, nausea, diarrhea and other digestive effects can occur. Check fish/shellfish or botanical allergy risks and the actual formulation.
- Cod-liver oil adds vitamins A and D; total all labeled sources and do not substitute it automatically for fish-body or algal oil. Pregnancy/breastfeeding needs source-specific advice, including fish-contaminant and vitamin considerations.
- Do not replace a prescription with an over-the-counter blend or self-treat very high triglycerides. Check EPA/DHA amounts, not only total oil weight; more is not automatically better.
- No universally established ideal omega-6:omega-3 ratio or routine requirement for extra omega-6/omega-9 capsules is established here.
Similar items and how they compare
- Fish or algal omega-3 oil
Can provide preformed EPA and/or DHA found in some omega blends.
EPA/DHA content varies; some algal products are mainly DHA. Source, chemical form, serving and drug versus supplement status matter.
- Flaxseed oil and walnuts
Provide the plant omega-3 ALA.
ALA remains nutritionally useful but conversion to EPA and especially DHA is limited; it is not a gram-for-gram replacement.
- Olive oil and ordinary seed oils
Provide common dietary omega-9 and/or omega-6 fats.
These are foods with their own fatty-acid profiles, not substitutes for a prescribed EPA product or proof that an extra 3–6–9 supplement is needed.
Sources, molecules and chemical forms
This is a group of fats, not one botanical remedy. Plant seeds/fruits can supply ALA, linoleic and oleic acids; fish, krill and cultivated microalgae supply differing amounts of EPA/DHA. Fish-body oil differs from vitamin-containing fish-liver oil. Triglyceride, ethyl-ester, free-fatty-acid and phospholipid products differ chemically, while an algal label alone does not guarantee both EPA and DHA.
Essential fats and conversion limits
Humans must obtain ALA and linoleic acid from food. Oleic acid can be synthesized, so it is not an essential nutrient. ALA conversion to long-chain omega-3s is limited and variable; reported overall conversion is below 15%, with DHA formation particularly constrained. This metabolic limitation is different from failure to absorb the ALA eaten. Direct EPA/DHA and plant ALA therefore need separate accounting.
Adult reference intakes are not medicinal doses
U.S. AIs for ALA are 1.6 g/day for adult men and 1.1 g/day for adult women; pregnancy and lactation values are 1.4 and 1.3 g/day. Linoleic-acid AIs are 17/12 g/day for men/women aged 19–50 and 14/11 g/day at 51 or older; pregnancy/lactation use 13 g/day. An AI estimates adequate total intake, rather than a proven minimum or capsule target. The U.S. has no EPA/DHA RDA; EFSA sets a separate adult AI of 250 mg/day combined EPA+DHA. Oleic acid has no essential-fat intake requirement.
Meaningful food portions
Examples are 7.26 g ALA in 1 tablespoon flaxseed oil, 2.57 g in 1 ounce English walnuts, and 1.28 g in 1 tablespoon canola oil. A cooked 3-ounce farmed Atlantic salmon serving supplies about 0.59 g EPA and 1.24 g DHA. These are food-table values, not guaranteed values for every fish or brand. Ordinary nuts and plant oils also supply omega-6/omega-9; their use can replace saturated fats rather than simply adding extra oil and energy.
No established universal omega ratio
Omega-6 is a family, and its essential linoleic acid should not be portrayed as categorically harmful. The AHA supports omega-6 within a healthy dietary pattern, particularly when replacing saturated fat. No ideal omega-6:omega-3 ratio is established for everyone, and a ratio can obscure whether either absolute intake is appropriate. “3–6–9” is a blend description, not evidence of balance, superior absorption or a need for three supplements.
Food, supplement and prescription evidence are different
In VITAL, 25,871 older adults received a 1 g/day marine-oil capsule containing 460 mg EPA and 380 mg DHA or placebo. Over 5.3 years, the main combined cardiovascular outcome was not significantly reduced (hazard ratio 0.92, 95% CI 0.80–1.06), nor was invasive cancer. Some secondary outcomes differed. The result does not make food sources useless, but it prevents presenting a routine omega capsule as a proven general heart-attack, stroke or cancer prevention strategy.
Prescription EPA benefit is product- and population-specific
REDUCE-IT randomized 8,179 statin-treated people with elevated triglycerides and established cardiovascular disease or diabetes plus risk factors. Prescription icosapent ethyl, 4 g/day, reduced the primary cardiovascular composite from 22.0% to 17.2% over median 4.9 years versus mineral-oil placebo. The absolute difference was 4.8 percentage points; it cannot be generalized to an unspecified fish-oil capsule, ALA oil or 3–6–9 blend. Formulation, selected population and comparator matter.
EPA/DHA prescription products are not equivalent to EPA-only
STRENGTH tested 4 g/day of an EPA/DHA carboxylic-acid formulation in 13,078 high-risk statin-treated participants and did not show cardiovascular superiority to corn-oil placebo. Separately, LOVAZA is labeled for severe hypertriglyceridemia (at least 500 mg/dL), with cardiovascular outcome benefit undetermined and possible LDL-cholesterol increases requiring monitoring. Lowering a laboratory triglyceride value and preventing cardiovascular events are different outcomes.
Atrial-fibrillation and bleeding signals
The current VASCEPA label reports hospitalization for atrial fibrillation/flutter in 3% versus 2% of trial participants, with greater incidence in people with prior rhythm problems. Bleeding occurred in 12% versus 10%, including serious bleeding in 3% versus 2% (rounded label figures); antithrombotic co-treatment increased bleeding incidence. These findings concern a high-dose prescription product and selected cardiovascular patients. They warrant individual review without implying that an ordinary fish meal carries the same risk.
Medication and everyday safety nuance
High-dose oils deserve review with warfarin, other anticoagulants or antiplatelets, particularly when bleeding risk or a procedure is relevant. Monitoring is preferable to independently stopping prescribed drugs. VITAL did not find significantly more major bleeding with its lower-dose formulation, illustrating why product/dose distinctions matter. Taste, reflux and digestive upset are possible. Check allergies, pregnancy/lactation context, and the extra vitamins A/D in fish-liver oils rather than assuming all marine oils are interchangeable.
Absorption and preparation
A small older human comparison found greater ethyl-ester EPA/DHA uptake with a 44 g-fat meal than previously measured with an 8 g-fat meal. That experimental comparison does not prescribe a high-fat diet. Follow the product’s meal instructions; VASCEPA is labeled to be taken with food. Formulation, food and adherence affect exposure, while clinical benefit still requires clinical-outcome evidence. Keep edible oils properly stored and use cooking methods appropriate to their labels.
Label reading and combinations
The front-of-bottle mass of “fish oil” is not the EPA+DHA dose. Read milligrams of each fatty acid per actual serving and the number of capsules in that serving, plus any vitamins or other actives. A food-based diet, a dietary supplement and a prescription have distinct roles. This entry does not recommend an omega stack, prescribe a dose, or assume extra omega-6/omega-9 is needed merely because those fats appear in a blend.
Entry sources
- NIH Office of Dietary Supplements: Omega-3 fatty acids, health professional fact sheet
- NCCIH: Omega-3 supplements, usefulness and safety
- National Academies: Dietary Reference Intakes, summary tables for essential fatty acids
- EFSA: Dietary Reference Values summary report, dietary fats
- DailyMed: VASCEPA (icosapent ethyl), prescribing information revised April 2026
- DailyMed: LOVAZA (omega-3-acid ethyl esters), prescribing information
- Lawson and Hughes (1988): Fish-oil absorption with low- and high-fat meals
- Manson et al. (2019): VITAL randomized trial of marine omega-3 fatty acids
- Bhatt et al. (2019): REDUCE-IT randomized trial of icosapent ethyl
- Nicholls et al. (2020): STRENGTH randomized trial of EPA/DHA carboxylic acids
- American Heart Association: Fats in foods and replacement of saturated fats
- American Heart Association: Omega-6 fatty acids and cardiovascular disease science advisory
- American Heart Association: Healthy cooking oils and storage
Reference entry 53 · Recorded content review: 2026-10-05 · Review scope and dates


